← FDA DRUG APPROVALS

FDA ANDA · ANDA084211

PROBENECID

Sponsor: AUROBINDO PHARMA USA

APPLICATION
ANDA084211
TYPE
ANDA
ORIGINAL APPROVAL
1976-01-13
LATEST ACTION
1998-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROBENECIDDiscontinued
PROBENECID 500MG · TABLET · ORAL

Approval history

1998-02-25Manufacturing (CMC) · Supplement 151AP
1997-07-08Manufacturing (CMC) · Supplement 150AP
1996-04-24Manufacturing (CMC) · Supplement 148AP
1996-04-24Labeling · Supplement 149AP
1994-08-30Manufacturing (CMC) · Supplement 147AP
1990-04-20Labeling · Supplement 145AP
1990-01-31Manufacturing (CMC) · Supplement 144AP
1990-01-12Labeling · Supplement 143AP
1989-05-18Labeling · Supplement 142AP
1988-04-26Labeling · Supplement 141AP
1988-01-15Manufacturing (CMC) · Supplement 140AP
1986-07-03Manufacturing (CMC) · Supplement 138AP
1984-11-15Manufacturing (CMC) · Supplement 136AP
1984-10-22Manufacturing (CMC) · Supplement 135AP
1983-03-30Manufacturing (CMC) · Supplement 133AP
1983-02-17Manufacturing (CMC) · Supplement 134AP
1982-06-02Manufacturing (CMC) · Supplement 131AP
1982-06-02Manufacturing (CMC) · Supplement 132AP
1976-01-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →